Business Wire

Gennao Bio Debuts Preclinical Data for First-in-Class Antibody-Drug Conjugate from Gene Monoclonal Antibody Platform (GMAB ADC)

HOPEWELL, N.J.--(BUSINESS WIRE)--Gennao Bio, a privately held genetic medicines company developing first-in-class, targeted nucleic acid therapeutics, today announced new preclinical results on the ...
Business Wire

ReSync Bio Launches to Automate Data and Operations in Drug Discovery

SAN FRANCISCO--(BUSINESS WIRE)--ReSync Bio, a scientific software provider accelerating preclinical R&D, today announced the company’s launch and a fundraise from Caffeinated Capital, Atria Ventures ...
pharmaphorum

BIO 2025: As pharma deploys AI across the value chain, data remains a challenge

(R to L) EY's Ricardo Vilanova, Lila Bioscience's Molly Gibson, Merck's Iya Khalil, Insitro's Mary Rozenman, and Gallop Oncology's Luba Greenwood at BIO 2025. When Google shook the foundations of the ...
Óstáilte ar MSN

Entera Bio presents data on EB613 in post-menopausal women with osteoporosis

Entera Bio (ENTX) announced data selected for presentation at the American Society for Bone and Mineral Research 2025 Annual Meeting in Seattle, Washington, for its lead program EB613 which is in late ...
Óstáilte ar MSN

GRI Bio reports six-week lung function data in Phase 2a study of GRI-0621

GRI Bio (GRI) reported interim 6-week lung function results from its ongoing Phase 2a study evaluating GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis. In the second interim analysis, lung ...